Aside from that, Y Zuo et al. validated that PD-L1 promoted cisplatin-resistance in ovarian cancer [24], and Fang Wei et al. found that upregulation of PD-L1 specifically promoted CSCs expansion in colorectal cancer [25]. Here, CD274 is linked to ovarian carcinoma.